Oxatomide protects against degranulation of rat peritoneal mast cells during in vitro challenge with antigen or compound 48/80. Ultrastructural aspects
- 1 May 1981
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 11 (3) , 177-183
- https://doi.org/10.1007/bf01967611
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparative effects of oxatomide on the release of histamine from rat peritoneal mast cellsInflammation Research, 1981
- The multiple facets of histamine researchInflammation Research, 1981
- Phospholipid methylation affects immunoglobulin E-mediated histamine and arachidonic acid release in rat leukemic basophilsBiochemical and Biophysical Research Communications, 1980
- Effect of uncouplers of oxidative phosphorylation on microtubule location and surface structure in murine mast cellsThe Anatomical Record, 1979
- Effect of Cyclic AMP on Histamine Release Induced by Compound 48/80International Archives of Allergy and Immunology, 1979
- Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediatorsCellular and Molecular Life Sciences, 1977
- Clinical chemistry as a medical disciplineScandinavian Journal of Clinical and Laboratory Investigation, 1977
- A Simple Polychrome Stain for Conventionally Fixed Epon-Embedded TissuesStain Technology, 1975
- ELECTRON MICROSCOPE OBSERVATIONS ON COMPOUND 48/80-INDUCED DEGRANULATION IN RAT MAST CELLSThe Journal of cell biology, 1971
- Mast Cells and 5‐HT. Intracellular Release of 5‐Hydroxytryptamine (5‐HT) from Storage Granules during Anaphylaxis or Treatment with Compound 48/80Acta Physiologica Scandinavica, 1969